Spire Wealth Management Palatin Technologies Inc Transaction History

Spire Wealth Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$0.27 - $0.5 $21 - $40	81 Added 0.21%	37,981 $11,000
Q4 2021 Jan 14, 2022	SELL	$0.34 - $0.86 $8,500 - $21,500	-25,000 Reduced 39.75%	37,900 $19,000
Q1 2021 May 21, 2021	BUY	$0.68 - $1.25 $42,772 - $78,625	62,900 New	62,900 $43,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $10.3M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.